Physician profile
Joanne Smith
NPI 1508153149
$2,069.46
in general payments reported to CMS, 2019-2025
16 companies · $564 in 2025
The $564 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.31 · 2020: $24.80 · 2021: $54.11 · 2022: $209 · 2023: $368 · 2024: $753 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,684.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $609.15 | 2022-2025 | Alphagan P, Lumigan, Vuity |
| Alcon Vision LLC | $404.17 | 2019-2025 | Rocklatan, Total30, Clareon |
| Tarsus Pharmaceuticals, INC. | $223.47 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $193.14 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Dompe US, INC. | $123.26 | 2024 | Oxervate |
| Genentech USA, INC. | $103.77 | 2023-2025 | Vabysmo |
| Sun Pharmaceutical Industries INC. | $78.54 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $73.46 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Rxsight INC | $49.60 | 2024-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $47.92 | 2019-2021 | |
| Coopervision INC. | $42.15 | 2020-2023 | Clariti Contact Lens |
| Regeneron Healthcare Solutions, INC. | $35.05 | 2024 | Eylea Hd |
| Glaukos Corporation | $23.56 | 2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Shire North American Group INC | $22.99 | 2019 | |
| Allergan, INC. | $20.23 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $19.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.